4-iodophenyl-9-methylpentadecanoic acid has been researched along with technetium tc-99m tetrofosmin in 1 studies
| Studies (4-iodophenyl-9-methylpentadecanoic acid) | Trials (4-iodophenyl-9-methylpentadecanoic acid) | Recent Studies (post-2010) (4-iodophenyl-9-methylpentadecanoic acid) | Studies (technetium tc-99m tetrofosmin) | Trials (technetium tc-99m tetrofosmin) | Recent Studies (post-2010) (technetium tc-99m tetrofosmin) |
|---|---|---|---|---|---|
| 15 | 2 | 1 | 1,205 | 216 | 192 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, A; Fujimori, K; Kyuma, M; Nakata, T; Obara, F; Shimamoto, K; Tsuchihashi, K | 1 |
1 other study(ies) available for 4-iodophenyl-9-methylpentadecanoic acid and technetium tc-99m tetrofosmin
| Article | Year |
|---|---|
Impaired myocardial accumulation of 15-(p-iodophenyl)-9-(R,S)-methylpentadecanoic acid in a patient with hypertrophic cardiomyopathy and exercise-induced ischemia due to vasospasm.
Topics: Aged; Cardiomyopathy, Hypertrophic; Coronary Vasospasm; Exercise Test; Fatty Acids; Heart; Humans; Iodobenzenes; Male; Myocardial Ischemia; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals | 2000 |